- World rank, all time
- #34,946 of 42,892
- Rank in Germany
- #1,646 of 2,077
- Research works
- 135 ▲ 343% vs 2013–17
- Citations
- 2.3k 17.0 per fractional work
- Top-10% rate
- 1.4% record average 16.5%
- Open access
- 22% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.2×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.2×
- Immunology and Microbiology 5.7×
- Arts and Humanities 1.7×
- Medicine 1.6×
- Veterinary 1.5×
- Dentistry 1.3×
- Chemistry 1.2×
- Social Sciences 0.9×
- Neuroscience 0.5×
- Energy 0.3×
- Decision Sciences 0.3×
- Materials Science 0.3×
- Health Professions 0.3×
- Business, Management and Accounting 0.3×
- Computer Science 0.2×
- Engineering 0.2×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.1×
Who are the top researchers at Reaction Biology (Germany)?
Ranked on the composite score, Wolfgang Reinhard and Holger Weber lead among researchers whose main affiliation is Reaction Biology (Germany).
- 1 Wolfgang Reinhard Germany · #31,985 worldwide 105 citations · 53 works
- 2 Holger Weber Germany · #968,138 worldwide 43 citations · 15 works
Which keywords describe research at Reaction Biology (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Immunotherapy, Breast Cancer, Tumor Regression, Gene Therapy, Chemotherapy, Cancer Therapy and HER2.
- International Law
- CDK4/6 Inhibitors
- Epigenetic Regulation
- Immune Response
- Tumor Microenvironment
- Arginine Deprivation
- Therapeutic Antibodies
- Cell Cycle
- Macrophage
- Activation
- Tumor Targeting
- Apoptosis
- Chimeric Antigen Receptor
- Protein Microarrays
- High-Throughput Analysis
- Cancer Immunotherapy
- HER2
- Cancer Therapy
- Tumor Regression
- Immunotherapy
- Cancer
- Breast Cancer
- Gene Therapy
- Chemotherapy
- Trastuzumab
- Inflammation
- Immunity
- CAR T Cells
- Regulation
- Metastatic Breast Cancer
- Cell Cycle Control
- Cell Proliferation
- Transcriptional Regulation
- Fc Receptors
- p53
- Bacterial Therapy
- Gene Expression
- Arginine Methylation
- Protein Arginine Methyltransferases
- Global Trade
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer6▲ 7.6×6 topics
- Immunotherapy5▲ 14×5 topics
- Breast Cancer5▲ 36×2 topics
- Tumor Regression4▲ 75×2 topics
- Gene Therapy4▲ 41×4 topics
- Cancer Therapy4▲ 12×4 topics
- Chemotherapy4▲ 9.5×4 topics
- HER23▲ 216×1 topic
- Trastuzumab3▲ 136×1 topic
- Cancer Immunotherapy3▲ 38×3 topics
- Inflammation3▲ 2.7×3 topics
- High-Throughput Analysis3▲ 144×1 topic
- Immunity3▲ 13×2 topics
- Protein Microarrays3▲ 299×1 topic
- CAR T Cells3▲ 66×1 topic
- Chimeric Antigen Receptor3▲ 66×1 topic
- Regulation3▲ 9.0×3 topics
- Apoptosis2▲ 15×2 topics
- Metastatic Breast Cancer2▲ 82×2 topics
- Tumor Targeting2▲ 26×2 topics
- Cell Cycle Control2▲ 148×2 topics
- Activation2▲ 73×1 topic
- Cell Proliferation2▲ 51×2 topics
- Macrophage2▲ 60×1 topic
- Transcriptional Regulation2▲ 27×3 topics
- Cell Cycle2▲ 123×1 topic
- Fc Receptors2▲ 76×1 topic
- Therapeutic Antibodies2▲ 60×1 topic
- p532▲ 179×1 topic
- Arginine Deprivation2▲ 95×1 topic
- Bacterial Therapy2▲ 95×1 topic
- Tumor Microenvironment2▲ 7.7×4 topics
- Gene Expression2▲ 5.3×5 topics
- Immune Response2▲ 5.6×5 topics
- Arginine Methylation2▲ 102×1 topic
- Epigenetic Regulation2▲ 13×2 topics
- Protein Arginine Methyltransferases2▲ 102×1 topic
- CDK4/6 Inhibitors1▲ 99×1 topic
- Global Trade1▲ 13×2 topics
- International Law1▲ 8.1×2 topics
Which research topics does Reaction Biology (Germany) publish most on?
By volume in 2022–2025: HER2/EGFR in Cancer Research, Advanced Biosensing Techniques and Applications, CAR-T cell therapy research and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HER2/EGFR in Cancer Research Oncology 3 works
- 2 Advanced Biosensing Techniques and Applications Molecular Biology 3 works
- 3 CAR-T cell therapy research Oncology 3 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 5 Immune cells in cancer Immunology 2 works
- 6 Cancer-related Molecular Pathways Oncology 2 works
- 7 Cancer Research and Treatments Biotechnology 2 works
- 8 Cancer-related gene regulation Molecular Biology 2 works
- 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 10 Cancer Treatment and Pharmacology Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Reaction Biology (Germany)'s research output changed?
Output in 2018–2022 was 343% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Freiburg im Breisgau
- University of Freiburg
- University Medical Center Freiburg
- Klinik für Frauenheilkunde
- Fraunhofer Institute for Solar Energy Systems
- Fraunhofer Institute for Applied Solid State Physics
- Max Planck Institute for the Study of Crime, Security and Law
- Max Planck Institute of Immunobiology and Epigenetics
- University of Education Freiburg
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.